Australian Pharmaceutical Patents Expiring January 2014

Below is a report from IP Organisers (an independent service company of Phillips Ormonde Fitzpatrick) detailing Australian Pharmaceutical Patents (that have been granted extensions) and that are due to expire in the coming month.

This report covers 2 Australian patents whose Extension of Term expires in January 2014.  Best wishes for the holiday season and new year from the team at IP Organisers!

ip org


Australian Pharmaceutical Patents

Expiring January 2014

Active Ingredients Enalapril maleate; Hydrochlorothiazide
Trade Name Renitec Plus
Chemical Name (S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline, (Z)-2-butenedioate salt (1:1) | 6-chloro-3,4-dihydro-2H-1,2,4-benzo-thiadiazine-7-sulfonamide 1,1-dioxide
Chemical Structure 78
Australian Patent AU-B-686097
Expiry Date 7 January 2014
Patent Assignee Merck Sharp & Dohme Corp.
Title Combinations of ACE inhibitors and diuretics
Abstract Pharmaceutical formulations comprising as active ingredients an angiotensin converting enzyme (ACE) inhibitor at a dose level normally found effective as an antihypertensive and a diuretic at a dose level below its minimum effective dose, demonstrate greater efficacy than would be expected in returning the blood pressure of hypertensive patients to normotensive values.
Australian Register of Therapeutic Goods ARTG ID 67439
Consumer Medicine Information Renitec Plus (Enalapril maleate; Hydrochlorothiazide)
Product Information Renitec Plus (Enalapril maleate; Hydrochlorothiazide)
Active Ingredient Tolterodine tartrate
Trade Name Detrusitol
Chemical Name (R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine L-hydrogen tartrate
Chemical Structure  9
Australian Patent AU-B-635493
Expiry Date 20 January 2014
Patent Assignee Pharmacia & Upjohn AB
Title New amines, their use and preparation
Abstract Novel 3,3-diphenylpropylamines of formula (I) wherein R1 signifies hydrogen or methyl, R2, R3 and R4 independently signify hydrogen, methyl, methoxy, hydroxy, carbamoyl, sulphanoyl or halogen, and X represents a tertiary amino group -NR5, R6, wherein R5 and R6signify non-aromatic hydrocarbyl groups, which may be the same or different and which together contain at least three carbon atoms, and which may form a ring together with the amine nitrogen, their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers, their use as drugs, especially as anticholinergic agents, their use for preparing an anticholinergic drug, pharmaceutical compositions containing the novel amines, and methods for preparing the same.
Australian Register of Therapeutic Goods ARTG ID 99393ARTG ID 99394
Consumer Medicine Information Detrusitol (Tolterodine tartrate)
Product Information Detrusitol (Tolterodine tartrate)

For further information please contact Rodney Chiang-Cruise or Aaron McMillan at IP Organisers Pty Ltd